Axogen, Inc.
For the period ended Dec 31, 2025. Filed Feb 24, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 24, 2026
AXGN$50.89+0.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Financial Statements and Supplementary Data
| Table of Contents | |
|---|---|
| Page | |
| REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM (PCAOB ID No.34) | 69 |
| CONSOLIDATED BALANCE SHEETS AS OF DECEMBER 31, 2025 AND 2024 | 71 |
| CONSOLIDATED STATEMENTS OF OPERATIONS FOR THE YEARS ENDED DECEMBER 31, 2025, 2024 AND 2023 | 72 |
| CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY FOR THE YEARS ENDED DECEMBER 31, 2025, 2024 AND 2023 | 73 |
| CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE YEARS ENDED DECEMBER 31, 2025, 2024 AND 2023 | 74 |
| NOTES TO CONSOLIDATED FINANCIAL STATEMENTS | 75 |
| SCHEDULE II VALUATION AND QUALIFYING ACCOUNTS | 102 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.